ArticleLeukemia2020

Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms.

Julian Baumeister et al.PubMed ↗Publisher ↗

No numbers read from the abstract.